1. Home
  2. DHC vs NVAX Comparison

DHC vs NVAX Comparison

Compare DHC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$6.72

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.46

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHC
NVAX
Founded
1998
1987
Country
United States
United States
Employees
585
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
DHC
NVAX
Price
$6.72
$8.46
Analyst Decision
Buy
Hold
Analyst Count
2
9
Target Price
$7.25
$11.33
AVG Volume (30 Days)
2.0M
4.4M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
0.58%
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$3.13
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
$3.47
Revenue Growth
N/A
64.69
52 Week Low
$2.00
$5.01
52 Week High
$7.66
$11.85

Technical Indicators

Market Signals
Indicator
DHC
NVAX
Relative Strength Index (RSI) 46.64 38.12
Support Level $3.85 $8.01
Resistance Level $6.85 $9.05
Average True Range (ATR) 0.30 0.54
MACD -0.10 -0.23
Stochastic Oscillator 20.76 1.81

Price Performance

Historical Comparison
DHC
NVAX

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: